Table 2.
Cohort | N | BMI (kg/m2) | Liver Fat | Insulin Sensitivity (HOMA-IR) | S-Triglycerides (mmol/L) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
I148II | I148IM | I148MM | I148II | I148IM | I148MM | I148II | I148IM | I148MM | I148II | I148IM | I148MM | ||
Multiethnic 1 [12] | 2111 | 30.4 | 31.1 | 30.0 | 3.7% a | 4.6% a | 7.7% ***,a | 3.3 | 3.5 | 3.3 | 1.32 | 1.35 | 1.41 |
31.6 | 32.0 | 32.2 | 3.1% | 4.8% | 4.8% *** | 3.3 | 3.3 | 4.4 | 0.97 | 0.97 | 1.02 | ||
29.2 | 28.8 | 28.8 | 3.5% | 3.7% | 3.5% *** | 2.3 | 2.4 | 2.0 | 1.25 | 1.21 | 0.90 | ||
Germany [79] | 330 | 29.9 | 29.1 | 28.7 | 5.4% a | 6.0% a | 7.2% ***,a | 12.6 v,z | 12.9 v,z | 12.9 v,z | NA | NA | NA |
Finnish [80] | 291 | 30.5 | 30.0 | 32.2 | 9.0% a | 10.4% *,a | 14.1% **,a | 72 y,z | 70 y,z | 74 y,z | 1.82 | 1.60 | 1.52 |
British [81] | 98 | 34.6 | 33.2 | 31.7 | 26.7% a | 28.8% a | 33.5% a | 2.4 | 3.1 | 2.6 | 1.60 | 1.70 | 1.40 |
Multiethnic 2 [82] | 1214 | NA × | NA × | NA × | 57 b | 55 b | 46 ***,b | NA × | NA× | NA× | NA × | NA × | NA × |
55 | 51 | 47 *** | |||||||||||
Dutch [83] | 470 | 37.7 | 37.6 | 37.6 | 66% c | 78% c | 100% ***,c | 2.7 | 2.8 | 2.9 | 1.42 | 1.47 | 1.46 |
Italian [84] | 61 | 25.7 | 25.9 | 16% d | 32% *,d | 3.4 | 4.7 | 1.13 | 1.15 | ||||
Italian [85] | 253 | 30.7 | 30.7 | 29.8 | 44% c | 48% c | 63% **,c | 3.9 | 4 | 5.2 | 1.64 | 1.85 | 1.79 |
Italian [86] | 211 | 32.1 | 30.4 | 31.7 | 4 e | 4 e | 4 e | 3.5 | 3.5 | 2.8 | 1.77 | 1.59 | 1.26 ** |
Taiwanese [87] | 879 | 23.3 | 23.6 | 23.6 | 13% f | 19% f | 23% *,f | 1.4 | 1.5 | 1.5 | 1.11 | 1.16 | 1.38 * |
South Korean [88] | 1363 | 24.7 | 24.4 | 23.9 ** | 38% f | 45% f | 54% *,f | 2.3 | 2.1 | 1.6 ** | 1.54 | 1.38 | 1.31 ** |
Taiwanese, pediatric [89] | 520 | 26.3 | 26.2 | 25.9 | 21% f | 13% f | 30% **,f | 2.4 | 2.5 | 1.7 | 1.11 | 1.03 | 0.94 |
Italian, pediatric [90] | 475 | NA | NA | NA | 13% f | 19% f | 41% *,f | 3.3 | 3.0 | 3.0 | 0.56 | 0.56 | 0.53 |
Italian, pediatric [91] | 149 | 95.2 | 95.0 | 94.1 | 70% g | 7% g | 4% ***,g | 2.5 | 2.7 | 2.4 | 1.28 | 1.19 | 1.39 |
30% | 78% | 4% | |||||||||||
0% | 15% | 92% |
BMI, body mass index; CT, computed tomography; HOMA-IR, Homeostasis model assessment of insulin resistance [62]; HU, Houndsfield Unit; MRI, magnetic resonance imaging; NA, not available; OGTT, oral glucose tolerance test; US, ultrasound. * Significant difference between groups in ANOVA or t test. * p < 0.05; ** p < 0.01, *** p < 0.0001. Data are presented as mean or median. 1 Caucasian, African and Hispanic Americans; 2 Hispanic and African Americas. BMI centiles; a 1H-MRS (liver fat content,%); b CT (liver density, HU); c Histology (prevalence of steatosis, %); d Histology (% hepatocytes steatotic); e US (severity of steatosis by Hamaguchi score, 3–4 = moderate); f US (prevalence of steatosis, %); g Histology (severity of steatosis, grade 1/2/3); v OGTT (arbitrary unit); y fasting serum insulin (pmol/L); z hyperinsulinemic clamp was also performed, data not shown in the table; × Data not shown, but it was reported that genetic variation at rs738409 did not correlate with HOMA-IR, insulin sensitivity index, BMI or S-triglycerides.